GB201813531D0 - Modified liposomes for use in the treatment of haemophilia - Google Patents
Modified liposomes for use in the treatment of haemophiliaInfo
- Publication number
- GB201813531D0 GB201813531D0 GBGB1813531.9A GB201813531A GB201813531D0 GB 201813531 D0 GB201813531 D0 GB 201813531D0 GB 201813531 A GB201813531 A GB 201813531A GB 201813531 D0 GB201813531 D0 GB 201813531D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- haemophilia
- treatment
- modified liposomes
- liposomes
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1813531.9A GB201813531D0 (en) | 2018-08-20 | 2018-08-20 | Modified liposomes for use in the treatment of haemophilia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1813531.9A GB201813531D0 (en) | 2018-08-20 | 2018-08-20 | Modified liposomes for use in the treatment of haemophilia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201813531D0 true GB201813531D0 (en) | 2018-10-03 |
Family
ID=63668070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1813531.9A Ceased GB201813531D0 (en) | 2018-08-20 | 2018-08-20 | Modified liposomes for use in the treatment of haemophilia |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201813531D0 (en) |
-
2018
- 2018-08-20 GB GBGB1813531.9A patent/GB201813531D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258396A1 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| IL272300A (en) | Mavacamten for use in the treatment of hypertrophic cardiomyopathy | |
| IL290150A (en) | Compositions and methods for the treatment of chronic pain | |
| IL272121A (en) | Composition and methods for the treatment of myopia | |
| HK1256164A1 (en) | Agents for use in the treatment of glioma | |
| HK1257588A1 (en) | Medicine for preventing and treating lung fibrosis and use of the medicine | |
| IL246855A0 (en) | Agents for use in the treatment of retinal inflammation | |
| IL277805A (en) | Use of gaboxadol in the treatment of substance use disorders | |
| IL274363B1 (en) | Use of specific sirna against protein s for the treatment of hemophilia | |
| IL281997A (en) | Combination therapy for the treatment of uveal melanoma | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| EP3199163A4 (en) | Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies | |
| HK1257591A1 (en) | Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| SI3668856T1 (en) | Novel tetrazole compounds and their use in the treatment of tuberculosis | |
| IL259383A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| GB201813531D0 (en) | Modified liposomes for use in the treatment of haemophilia | |
| IL273863A (en) | Device for use in the treatment of hemorrhoids | |
| GB201905796D0 (en) | Modified liposomes for use in the treatment of haemophilia | |
| EP3648789C0 (en) | Mtmr2-s polypeptide for use in the treatment of myopathies | |
| GB201820451D0 (en) | Compounds and their use for the treatment of alpha1-antitryspin deficiency | |
| GB201820455D0 (en) | Compounds and their use for the treatment of alpha1-antitryspin deficiency | |
| GB201820452D0 (en) | Compounds and their use for the treatment of alpha1-antitryspin deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |